120890-75-7 Usage
Description
2-BROMO-5-ETHOXY-BENZOIC ACID is a chemical compound with the molecular formula C9H9BrO3, which is a derivative of benzoic acid featuring a bromine atom and an ethoxy group attached to the benzene ring. 2-BROMO-5-ETHOXY-BENZOIC ACID is known for its wide range of applications across various fields, including medicine, agriculture, and industrial chemistry.
Uses
Used in Pharmaceutical Synthesis:
2-BROMO-5-ETHOXY-BENZOIC ACID is used as a key intermediate in the synthesis of various pharmaceuticals and organic compounds. Its unique structure allows it to be a valuable building block for the development of new drugs and therapeutic agents.
Used in Chemical Production:
In the field of industrial chemistry, 2-BROMO-5-ETHOXY-BENZOIC ACID serves as an intermediate in the production of other chemicals. Its versatility in chemical reactions makes it an essential component in the synthesis of a variety of chemical products.
Used in Agricultural Applications:
2-BROMO-5-ETHOXY-BENZOIC ACID also finds use in agriculture, where it may be employed as a component in the development of agrochemicals or as a building block for the synthesis of compounds with pesticidal properties.
It is important to handle 2-BROMO-5-ETHOXY-BENZOIC ACID with care, as it can be hazardous if not used properly. Proper safety measures should be taken to minimize any potential risks associated with its use.
Check Digit Verification of cas no
The CAS Registry Mumber 120890-75-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,0,8,9 and 0 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 120890-75:
(8*1)+(7*2)+(6*0)+(5*8)+(4*9)+(3*0)+(2*7)+(1*5)=117
117 % 10 = 7
So 120890-75-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H9BrO3/c1-2-13-6-3-4-8(10)7(5-6)9(11)12/h3-5H,2H2,1H3,(H,11,12)
120890-75-7Relevant articles and documents
NOVEL COMPOUNDS
-
Page/Page column 22, (2010/02/12)
The present invention relates to novel phenylalanine compounds, processes for their preparation, compositions comprising them and their use in the treatment or prevention of diseases capable of being modulated by the inhibition of cell adhesion.
